Stryker receives fda clearance for sahara® lateral 3d expandable interbody system

Stryker announced the u.s. food and drug administration (fda) 510(k) clearance of its sahara lateral 3d expandable interbody system featuring lamellar 3d titanium technology, which will be on display at the society for minimally invasive spine surgery (smiss) annual forum this week in las vegas, nv. sahara lateral is the first ever 3d-printed lateral expandable fusion device and features passive expansion capabilities that are designed to allow surgeons to achieve up to 30 degrees of sagittal spinal correction in skeletally mature patients. utilizing a passive expansion mechanism, the implant can either be adjusted from a lateral approach intraoperatively or can adjust passively in a staged posterior approach following osteotomy. sahara lateral features lamellar 3d titanium technology, which uses an advanced 3d printing method to create structures that were previously difficult or impossible to manufacture using traditional manufacturing techniques. starting with a titanium powder, the sahara implants are grown through the selective application of a high-energy laser beam, incorporating complex internal geometries and a roughened surface architecture. roughened titanium surfaces have been shown to demonstrate increased protein expression in contrast to smooth titanium surfaces. sahara lateral complements the sahara anterior lumbar expandable stabilization system, a lordotic expandable device with integrated screw fixation. sahara lateral is available in a variety of footprints, heights and lordotic offerings designed to more precisely match a patient's anatomy and is intended to be used with supplemental fixation systems cleared for use in the lumbar spine.
SYK Ratings Summary
SYK Quant Ranking